|
Index of reports
> Cases with Nausea (173)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Fluorouracil where reactions include nausea. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 173 Next >>
Possible Fluorouracil side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male, weighing 100.7 kg (221.5 pounds)
Reactions: Nausea, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: no treatment
Indication: Squamous Cell Carcinoma
Blinded NO Treatment Received
Dosage: no treatment
Indication: Squamous Cell Carcinoma
Fluorouracil
Dosage: 1400 mg/24hrs civ over 120 hours
Indication: Squamous Cell Carcinoma
Start date: 2012-07-01
End date: 2012-07-06
Fluorouracil
Dosage: unk
Start date: 2012-07-29
Fluorouracil
Dosage: 1400 mg/24hrs civ over 120 hours
Start date: 2012-07-15
End date: 2012-07-20
Hydroxyurea
Dosage: unk
Administration route: Oral
Start date: 2012-07-29
Hydroxyurea
Dosage: 500 mg, bid
Administration route: Oral
Start date: 2012-07-15
End date: 2012-07-20
Hydroxyurea
Dosage: 500 mg, bid
Administration route: Oral
Indication: Squamous Cell Carcinoma
Start date: 2012-07-01
End date: 2012-07-06
Paclitaxel
Dosage: 228 mg qwk
Start date: 2012-07-15
End date: 2012-07-20
Paclitaxel
Dosage: unk
Start date: 2012-07-29
Paclitaxel
Dosage: 228 mg qwk
Indication: Squamous Cell Carcinoma
Start date: 2012-07-02
Placebo
Dosage: no treatment
Indication: Squamous Cell Carcinoma
Other drugs received by patient: Fentanyl; Neosporin (Neomycin Sulfate / Polymyxin B Sulfate); Senna; Bacitracin; Filgrastim; Morphine; Famotidine; Fluconazole; Eucerin; Prochlorperazine; Esomeprazole Sodium; Guaifenesin; Enoxaparin; Amoxicillin and Clavulanate Potassium; Miralax; Lidocaine; Escitalopram; Ondansetron; Rosuvastatin; Docusate; Aquaphor; Hydromorphone Hydrochloride; Nystatin
Possible Fluorouracil side effects in
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20
Patient:
Reactions: Abdominal Pain, Vomiting, Hypersensitivity, Nausea, Skin Toxicity, Mucosal Inflammation, Fatigue, Diarrhoea, Hepatotoxicity, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Herceptin
Dosage: maintenance dose
Lapatinib
Dosage: arm b
Administration route: Oral
Indication: Breast Cancer
Lapatinib
Dosage: arm c
Administration route: Oral
Paclitaxel
Indication: Breast Cancer
Possible Fluorouracil side effects in 64 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15
Patient: 64 year old female
Reactions: Pruritus, Vomiting, Dyspnoea, Nausea, Chills, Pain, Pyrexia, Transaminases Increased, Fatigue, Diarrhoea, Rash Erythematous, Urine Colour Abnormal, Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorouracil
Dosage: dose unit:40
Administration route: Topical
Indication: Squamous Cell Carcinoma
Fluorouracil
Dosage: dose unit:40
Administration route: Topical
Indication: Actinic Keratosis
Other drugs received by patient: Zinc Oxide; Wrap Zinc Oxide
Possible Fluorouracil side effects in
Reported by a consumer/non-health professional from Germany on 2012-08-09
Patient:
Reactions: Nausea, Dysentery
Drug(s) suspected as cause:
Fluorouracil
Possible Fluorouracil side effects in male
Reported by a physician from Italy on 2012-08-08
Patient: male
Reactions: Vomiting, Psychomotor Hyperactivity, Nausea, Hyperammonaemia, Encephalopathy, Apallic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cisplatin
Dosage: 87 milligram daily;
Indication: Gastric Cancer
Start date: 2012-07-30
End date: 2012-07-30
Fluorouracil
Dosage: 1160 milligram daily;
Administration route: Oral
Indication: Gastric Cancer
Start date: 2012-07-30
End date: 2012-08-02
Other drugs received by patient: Flecainide Acetate; Toradol
Possible Fluorouracil side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07
Patient: 65 year old female, weighing 36.0 kg (79.2 pounds)
Reactions: Fatigue, Stomatitis, Nausea, Hyperkalaemia, Dehydration, Neutropenia, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: withdrawn on 30aug10
Indication: Head and Neck Cancer
Start date: 2010-08-16
End date: 2010-08-16
Fluorouracil
Indication: Head and Neck Cancer
Start date: 2010-08-16
End date: 2010-08-20
Other drugs received by patient: Emend; Hypromellose; Zofran; Artificial Tears; Levothyroxine Sodium; Dexamethasone; Oxycodone HCL
Possible Fluorouracil side effects in
Reported by a physician from Germany on 2012-08-07
Patient:
Reactions: Nausea, Dysentery
Drug(s) suspected as cause:
Fluorouracil
Possible Fluorouracil side effects in male
Reported by a physician from United States on 2012-08-03
Patient: male, weighing 100.7 kg (221.5 pounds)
Reactions: Nausea, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: no treatment received
Indication: Squamous Cell Carcinoma
Blinded NO Treatment Received
Dosage: no treatment received
Indication: Squamous Cell Carcinoma
Fluorouracil
Dosage: 1400 mg/24hrs civ over 120 hours
Start date: 2012-07-15
End date: 2012-07-20
Fluorouracil
Dosage: 1400 mg/24hrs civ over 120 hours
Indication: Squamous Cell Carcinoma
Start date: 2012-07-15
End date: 2012-07-06
Hydroxyurea
Dosage: 500 mg, unk
Administration route: Oral
Indication: Squamous Cell Carcinoma
Start date: 2012-07-01
End date: 2012-07-06
Hydroxyurea
Dosage: 500 mg, unk
Administration route: Oral
Start date: 2012-07-15
End date: 2012-07-20
Paclitaxel
Dosage: 228 mg qwk
Start date: 2012-07-15
End date: 2012-07-20
Paclitaxel
Dosage: 228 mg qwk
Indication: Squamous Cell Carcinoma
Start date: 2012-07-02
Placebo
Dosage: no treatment received
Indication: Squamous Cell Carcinoma
Other drugs received by patient: Bacitracin; Fentanyl Citrate; Miralax; Escitalopram; Senna-Mint WAF; Famotidine; Filgrastim; Fluconazole; Eucerin; Aquaphor; Prochlorperazine; Ondansetron; Lidocaine; Morphine Sulfate; Amoxicillin and Clavulanate Potassium; Neosporin (Neomycin Sulfate / Polymyxin B Sulfate); Rosuvastatin
Possible Fluorouracil side effects in female
Reported by a individual with unspecified qualification from United States on 2012-08-02
Patient: female, weighing 87.6 kg (192.7 pounds)
Reactions: Hypersensitivity, Oesophagitis Ulcerative, Dihydropyrimidine Dehydrogenase Deficiency, Nasopharyngeal Cancer, Skin Discolouration, Hypovolaemia, Vomiting, Stomatitis, Nausea, Urinary Tract Infection, Hypotension, Febrile Neutropenia, Hyponatraemia, Pancytopenia, Swollen Tongue, Rash, Mucosal Inflammation, Alopecia, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 159 mg
Fluorouracil
Dosage: 7960 mg
Possible Fluorouracil side effects in
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-31
Patient:
Reactions: Nausea
Drug(s) suspected as cause:
Cisplatin
Dosage: (df)
Indication: Oesophageal Carcinoma
Fluorouracil
Dosage: (df)
Indication: Oesophageal Carcinoma
Nedaplatin (Nedaplatin)
Dosage: (df)
Indication: Oesophageal Carcinoma
Therapeutic Radiopharmaceuticals (Therapeutic Radiopharmaceuticals)
Dosage: (10 mv x-rays, 2 gy daily)
Indication: Oesophageal Carcinoma
Other drugs received by patient: I.V. Solutions; Fludeoxyglucose
Possible Fluorouracil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Diarrhoea, Cholecystitis Acute, Nausea, Cholangitis, Pancreatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorouracil
Dosage: 1200 mg/m2 x 46 hours, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-07-05
Irinotecan Hydrochloride
Dosage: 150 mg/m2, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-07-05
LDE 225
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-05
End date: 2012-06-26
LDE 225
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-28
End date: 2012-07-13
LDE 225
Dosage: 200 mg, qd
Administration route: Oral
Indication: Adenocarcinoma Pancreas
Start date: 2012-04-24
End date: 2012-05-12
Leucovorin Calcium
Dosage: 400 mg/m2, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-07-05
Oxaliplatin
Dosage: 65 mg/m2, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-07-05
Other drugs received by patient: Reglan; Zofran; Celexa; Miralax; Fish OIL; Vitamin D; Lomotil; Creon; Dilaudid; Emend; Imodium; Oxycodone HCL; Decadron; Estrogens; Omeprazole; Ativan; Compazine
Possible Fluorouracil side effects in 69 year old male
Reported by a physician from Japan on 2012-07-30
Patient: 69 year old male, weighing 62.0 kg (136.4 pounds)
Reactions: Paronychia, Blood Bilirubin Increased, Abdominal Pain, Pruritus, Hepatic Failure, Pyrexia, Constipation, Disease Progression, Cholangitis, Onychoclasis, Thrombocytopenia, Colorectal Cancer, Dermatitis Acneiform, Colitis Ischaemic, Stomatitis, Nausea, Haemoglobin Decreased, Diarrhoea, Neutropenia, Leukopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Fluorouracil
Dosage: 3500 mg/body/d1-2 (1087 mg/m2/d1-2)
Start date: 2011-03-11
End date: 2011-03-11
Fluorouracil
Dosage: 3500 mg/body/d1-2 (1087 mg/m2/d1-2)
Start date: 2011-07-07
End date: 2011-07-07
Fluorouracil
Dosage: 3500 mg/body/d1-2 (1087 mg/m2/d1-2)
Start date: 2011-04-08
End date: 2011-04-08
Fluorouracil
Dosage: 3500 mg/body/d1-2 (1087 mg/m2/d1-2)
Start date: 2011-05-06
End date: 2011-05-06
Fluorouracil
Dosage: 3500 mg/body/d1-2 (1087 mg/m2/d1-2)
Start date: 2011-06-02
End date: 2011-06-02
Fluorouracil
Dosage: 625 mg/body (388.2 mg/m2), 1x/day
Start date: 2011-07-07
End date: 2011-07-07
Fluorouracil
Dosage: 625 mg/body (388.2 mg/m2), 1x/day
Start date: 2011-06-02
End date: 2011-06-02
Fluorouracil
Dosage: 625 mg/body (388.2 mg/m2), 1x/day
Indication: Colorectal Cancer
Start date: 2011-03-11
End date: 2011-03-11
Fluorouracil
Dosage: 625 mg/body (388.2 mg/m2), 1x/day
Start date: 2011-04-08
End date: 2011-04-08
Fluorouracil
Dosage: 625 mg/body (388.2 mg/m2), 1x/day
Start date: 2011-05-06
End date: 2011-05-06
Irinotecan Hydrochloride
Dosage: 240 mg/body (149.1 mg/m2), 1x/day
Start date: 2011-06-02
End date: 2011-06-02
Irinotecan Hydrochloride
Dosage: 240 mg/body (149.1 mg/m2), 1x/day
Start date: 2011-04-08
End date: 2011-04-08
Irinotecan Hydrochloride
Dosage: 240 mg/body (149.1 mg/m2), 1x/day
Start date: 2011-05-06
End date: 2011-05-06
Irinotecan Hydrochloride
Dosage: 240 mg/body (149.1 mg/m2), 1x/day
Start date: 2011-07-07
End date: 2011-07-07
Irinotecan Hydrochloride
Dosage: 240 mg/body (149.1 mg/m2), 1x/day
Indication: Colorectal Cancer
Start date: 2011-03-11
End date: 2011-03-11
Other drugs received by patient: Cefoperazone Sodium / Sulbactam Sodium; Seishoku; Soldem 1; Flomax; Vitamedin Intravenous; Cefdinir; Cefdinir; Loperamide Hydrochloride; Amino Acids NOS / Carbohydrates NOS / Electrolytes NOS; Levofolinate Calcium; Ascorbic Acid; Vectibix; Potassium Chloride; Metilon
Possible Fluorouracil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Cholecystitis Acute, Diarrhoea, Nausea, Cholangitis, Pancreatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorouracil
Dosage: 1200 mg/m2 x 46 hours, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-06-19
Irinotecan Hydrochloride
Dosage: 150 mg/m2, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-06-19
LDE 225
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-28
End date: 2012-07-13
LDE 225
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-05
End date: 2012-06-26
LDE 225
Dosage: 200 mg, qd
Administration route: Oral
Indication: Adenocarcinoma Pancreas
Start date: 2012-04-24
End date: 2012-05-12
Leucovorin Calcium
Dosage: 400 mg/m2, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-06-19
Oxaliplatin
Dosage: 65 mg/m2, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-06-19
Other drugs received by patient: Celexa; Miralax; Creon; Fish OIL; Dilaudid; Compazine; Omeprazole; Oxycodone HCL; Lomotil; Ativan; Decadron; Zofran; Emend; Estrogens; Vitamin D; Imodium; Reglan
Possible Fluorouracil side effects in female
Reported by a physician from United States on 2012-07-24
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Diarrhoea, Cholecystitis Acute, Nausea, Cholangitis, Pancreatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorouracil
Dosage: 1200 mg/m2 x 46 hours, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-06-19
Irinotecan Hydrochloride
Dosage: 150 mg/m2, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-06-19
LDE 225
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-05
End date: 2012-06-26
LDE 225
Dosage: 200 mg, qd
Administration route: Oral
Indication: Adenocarcinoma Pancreas
Start date: 2012-04-24
End date: 2012-05-12
LDE 225
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-06-28
End date: 2012-07-13
Leucovorin Calcium
Dosage: 400 mg/m2, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-06-19
Oxaliplatin
Dosage: 65 mg/m2, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-06-19
Other drugs received by patient: Imodium; Omeprazole; Reglan; Creon; Zofran; Ativan; Fish OIL; Lomotil; Compazine; Miralax; Dilaudid; Emend; Estrogens; Vitamin D; Celexa; Decadron; Oxycodone HCL
Possible Fluorouracil side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23
Patient: 72 year old female
Reactions: Dysarthria, Nausea, Bradykinesia, Dizziness, Leukoencephalopathy, Gait Disturbance
Drug(s) suspected as cause:
Cisplatin
Docetaxel
Fluorouracil
Possible Fluorouracil side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-23
Patient: 48 year old female
Reactions: Vomiting, Nausea, Febrile Neutropenia, Oropharyngeal Pain
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 830mg, every cycle; 800mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-27
Cyclophosphamide
Dosage: 830mg, every cycle; 800mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-06
End date: 2010-10-06
Epirubicin
Dosage: 166mg every cycle; 140mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-06
End date: 2010-10-06
Epirubicin
Dosage: 166mg every cycle; 140mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-27
Fluorouracil
Dosage: 830 mg every cycle; 700 mg, every cycle
Indication: Breast Cancer
Start date: 2010-10-06
Fluorouracil
Dosage: 830 mg every cycle; 700 mg, every cycle
Indication: Breast Cancer
Start date: 2010-10-27
Possible Fluorouracil side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23
Patient: 72 year old female
Reactions: Dysarthria, Nausea, Dizziness, Bradykinesia, Gait Disturbance, Leukoencephalopathy
Drug(s) suspected as cause:
Cisplatin
Docetaxel
Fluorouracil
Possible Fluorouracil side effects in male
Reported by a physician from United States on 2012-07-19
Patient: male, weighing 54.3 kg (119.5 pounds)
Reactions: Nausea, Anaemia, Failure To Thrive, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorouracil
Dosage: 1200 mg/m2, unk
Indication: Adenocarcinoma Pancreas
Start date: 2012-06-11
End date: 2012-06-25
Irinotecan HCL
Dosage: 150 mg/m2, unk
Indication: Adenocarcinoma Pancreas
Start date: 2012-06-11
End date: 2012-06-25
LDE 225
Dosage: 200 mg, unk
Administration route: Oral
Indication: Adenocarcinoma Pancreas
Start date: 2012-06-11
End date: 2012-06-25
Leucovorin Calcium
Dosage: 400 mg, unk
Indication: Adenocarcinoma Pancreas
Start date: 2012-06-11
End date: 2012-06-25
Oxaliplatin
Dosage: 65 mg/m2, unk
Indication: Adenocarcinoma Pancreas
Start date: 2012-06-11
End date: 2012-06-25
Other drugs received by patient: Baclofen; MS Contin; Emend; Morphine Sulfate; Prochlorperazine; Neulasta; Dexamethasone; Reglan; Ondansetron; Lorazepam
Possible Fluorouracil side effects in 51 year old female
Reported by a physician from Italy on 2012-07-18
Patient: 51 year old female
Reactions: Nausea, DRY Skin, Alopecia Areata, Hypertransaminasaemia
Drug(s) suspected as cause:
Erbitux
Indication: Rectal Cancer
Start date: 2010-07-23
Fluorouracil
Indication: Rectal Cancer
Start date: 2010-07-23
Irinotecan Hydrochloride
Indication: Rectal Cancer
Start date: 2010-07-23
Other drugs received by patient: Leucovorin Calcium
Possible Fluorouracil side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-17
Patient: female, weighing 56.3 kg (123.9 pounds)
Reactions: Flushing, Vomiting, Chest Discomfort, ECG Signs of Myocardial Ischaemia, Nausea
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Eloxatin
Dosage: 130 mg
End date: 2012-06-11
Fluorouracil
Dosage: 4327 mg
End date: 2012-06-13
Leucovorin Calcium
Dosage: 625 mg
End date: 2012-06-11
Other drugs received by patient: Singulair; Aspirin; Xalitan; Crestor; Synthroid
Possible Fluorouracil side effects in 72 year old male
Reported by a physician from United States on 2012-07-17
Patient: 72 year old male, weighing 65.0 kg (143.1 pounds)
Reactions: Death, Nausea, Hypotension, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Blinded Therapy
Indication: Gastric Cancer
Start date: 2012-01-27
Blinded Therapy
End date: 2012-05-02
Eloxatin
Indication: Gastric Cancer
Start date: 2012-01-27
End date: 2012-01-27
Eloxatin
Start date: 2012-05-02
End date: 2012-05-02
Fluorouracil
Dosage: 400 mg/m2 iv bolus followed by 2400 mg/m2 continuous iv for 46-48 hours
End date: 2012-05-02
Fluorouracil
Dosage: 400 mg/m2 iv bolus followed by 2400 mg/m2 continuous iv for 46-48 hours
Indication: Gastric Cancer
Start date: 2012-01-27
Leucovorin Calcium
Indication: Gastric Cancer
Start date: 2012-01-27
Leucovorin Calcium
End date: 2012-05-02
Other drugs received by patient: Lomotil; Atropine; Insulin Aspart; Sodium Chloride; Decadron; Diphenoxylate; Dextrose 5% and Sodium Chloride 0.45% IN Plastic Container; Octreotide Acetate; Kytril
Possible Fluorouracil side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-16
Patient: 64 year old male
Reactions: Dysgeusia, Vomiting, Nausea, Pneumomediastinum, Alopecia, Oesophageal Perforation, Neutrophil Count Decreased
Drug(s) suspected as cause:
Cisplatin
Dosage: (df)
Indication: Oesophageal Cancer Metastatic
Docetaxel
Dosage: (df)
Indication: Oesophageal Cancer Metastatic
Fluorouracil
Dosage: (df)
Indication: Oesophageal Cancer Metastatic
Possible Fluorouracil side effects in 72 year old male
Reported by a physician from United States on 2012-07-13
Patient: 72 year old male, weighing 65.0 kg (143.1 pounds)
Reactions: Death, Nausea, Hypotension, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Blinded Therapy
End date: 2012-05-02
Blinded Therapy
Indication: Gastric Cancer
Start date: 2012-01-27
Eloxatin
Start date: 2012-05-02
End date: 2012-05-02
Eloxatin
Indication: Gastric Cancer
Start date: 2012-01-27
End date: 2012-01-27
Fluorouracil
Dosage: 400 mg/m2 iv bolus followed by 2400 mg/m2 continuous iv for 46-48 hours
Indication: Gastric Cancer
Start date: 2012-01-27
Fluorouracil
Dosage: 400 mg/m2 iv bolus followed by 2400 mg/m2 continuous iv for 46-48 hours
End date: 2012-05-02
Leucovorin Calcium
Indication: Gastric Cancer
Start date: 2012-01-27
Leucovorin Calcium
End date: 2012-05-02
Other drugs received by patient: Dextrose 5% and Sodium Chloride 0.45% IN Plastic Container; Kytril; Lomotil; Sodium Chloride; Decadron; Octreotide Acetate
Possible Fluorouracil side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-12
Patient: 64 year old male
Reactions: Dysgeusia, Vomiting, Nausea, Alopecia, Pneumomediastinum, Neutrophil Count Decreased, Oesophageal Perforation
Drug(s) suspected as cause:
Cisplatin
Dosage: event: after 3 rd cycle
Docetaxel
Dosage: event after 3 rd cycle
Fluorouracil
Dosage: event: after 3 rd cycle
Possible Fluorouracil side effects in
Reported by a individual with unspecified qualification from China on 2012-07-12
Patient:
Reactions: Vomiting, Nausea
Drug(s) suspected as cause:
Fluorouracil
Dosage: 2400 mg/m2 intravenous
Indication: Colorectal Cancer Stage III
Leucovorin Calcium
Dosage: 200 mg/m2 intravenous
Indication: Colorectal Cancer Stage III
Oxaliplatin
Dosage: 85 mg/m2 intravenous
Indication: Colorectal Cancer Stage III
Other drugs received by patient: Granisetron; Dexamethasone
Possible Fluorouracil side effects in 51 year old female
Reported by a physician from Italy on 2012-07-11
Patient: 51 year old female
Reactions: Nausea, Alopecia, DRY Skin, Hypertransaminasaemia
Drug(s) suspected as cause:
Erbitux
Dosage: 630 mg, cyclic
Indication: Rectal Cancer
Start date: 2010-07-23
Fluorouracil
Dosage: 4100 mg, cyclic
Indication: Rectal Cancer
Start date: 2010-07-23
Irinotecan HCL
Dosage: 280 mg, cyclic
Indication: Rectal Cancer
Start date: 2010-07-23
Other drugs received by patient: Calcium Folinate
Possible Fluorouracil side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-11
Patient: female
Reactions: Vomiting, Nausea, Alopecia, Hypertransaminasaemia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Start date: 2011-06-08
End date: 2011-07-27
Epirubicin Hydrochloride
Indication: Breast Cancer
Start date: 2011-06-08
End date: 2011-07-27
Fluorouracil
Indication: Breast Cancer
Start date: 2011-06-08
End date: 2011-07-27
Other drugs received by patient: Decadron; Kytril; Estrone W / Progesterone; Ramipril
Possible Fluorouracil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-11
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Nausea, Diarrhoea, Cholangitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorouracil
Dosage: 1200 mg/m2 x 46 hours, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-06-19
Irinotecan Hydrochloride
Dosage: 150 mg/m2, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-06-19
LDE 225
Dosage: 200 mg, qd
Administration route: Oral
Indication: Adenocarcinoma Pancreas
Start date: 2012-04-24
End date: 2012-06-26
Leucovorin Calcium
Dosage: 400 mg/m2, qw2
Indication: Pancreatic Carcinoma Metastatic
Start date: 2012-04-24
End date: 2012-06-19
Oxaliplatin
Dosage: 65 mg/m2, qw2
Start date: 2012-04-24
End date: 2012-06-19
Other drugs received by patient: Celexa; Fish OIL; Vitamin D; Emend; Estrogens; Oxycodone HCL; Imodium; Omeprazole; Decadron; Reglan; Compazine; Zofran; Dilaudid; Ativan; Creon; Miralax
Possible Fluorouracil side effects in male
Reported by a physician from United States on 2012-07-06
Patient: male, weighing 54.3 kg (119.5 pounds)
Reactions: Nausea, Anaemia, Failure To Thrive, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Eloxatin
Dosage: 65 mg/m2, unk
Indication: Adenocarcinoma Pancreas
Start date: 2012-06-11
End date: 2012-06-25
Fluorouracil
Dosage: 1200 mg/m2, unk
Indication: Adenocarcinoma Pancreas
Start date: 2012-06-11
End date: 2012-06-25
Irinotecan HCL
Dosage: 150 mg/m2, unk
Indication: Adenocarcinoma Pancreas
Start date: 2012-06-11
End date: 2012-06-25
LDE 225
Dosage: 200 mg, unk
Administration route: Oral
Indication: Adenocarcinoma Pancreas
Start date: 2012-06-11
End date: 2012-06-25
Leucovorin Calcium
Dosage: 400 mg, unk
Indication: Adenocarcinoma Pancreas
Start date: 2012-06-11
End date: 2012-06-25
Other drugs received by patient: Emend; Morphine; Ondansetron; Dexamethasone; MS Contin; Prochlorperazine; Reglan; Baclofen; Neulasta; Lorazepam
Possible Fluorouracil side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-05
Patient:
Reactions: Vomiting, Nausea
Drug(s) suspected as cause:
Bevacizumab (Bevacizumab)
Dosage: (5 mg/kg, every other week)
Indication: Colorectal Cancer Metastatic
Fluorouracil
Dosage: (2000 mg/m2)
Indication: Colorectal Cancer Metastatic
Irinotecan HCL
Dosage: (100 mg/m2)
Indication: Colorectal Cancer Metastatic
Leucovorin Calcium
Dosage: (200 mg/m2)
Indication: Colorectal Cancer Metastatic
Page 1 Next >>
|
